סימול | YTM % | ווליום/נפח מסחר | מחיר % | קופון % | מועד פדיון | כמות יוצאת דופן | ערך נקוב | סכום נקוב מינימלי | מנפיק |
---|---|---|---|---|---|---|---|---|---|
RPHC5222528Royalty Pharma plc 3.35% 02-SEP-2051 | 7.19% | 4.58 M | 64.89% | 3.35% | 2051-09-02 | 700 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237919Royalty Pharma plc 3.55% 02-SEP-2050 | 7.00% | 1.93 M | 68.32% | 3.55% | 2050-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237891Royalty Pharma plc 3.3% 02-SEP-2040 | 6.71% | 1.34 M | 73.91% | 3.30% | 2040-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5824522Royalty Pharma plc 5.9% 02-SEP-2054 | 6.09% | 2.84 M | 98.01% | 5.90% | 2054-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5222527Royalty Pharma plc 2.15% 02-SEP-2031 | 5.62% | 150 K | 83.07% | 2.15% | 2031-09-02 | 600 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5824521Royalty Pharma plc 5.4% 02-SEP-2034 | 5.57% | 5.05 M | 98.96% | 5.40% | 2034-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237916Royalty Pharma plc 2.2% 02-SEP-2030 | 5.50% | 34 K | 85.66% | 2.20% | 2030-09-02 | 996.81 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5824520Royalty Pharma plc 5.15% 02-SEP-2029 | 5.06% | 1.59 M | 100.33% | 5.15% | 2029-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237354Royalty Pharma plc 1.75% 02-SEP-2027 | 5.00% | 40 K | 92.24% | 1.75% | 2027-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237914Royalty Pharma plc 1.2% 02-SEP-2025 | 4.93% | 1.04 M | 97.44% | 1.20% | 2025-09-02 | 999.96 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5035520Royalty Pharma plc 2.2% 02-SEP-2030 | 2.37% | 0 | 98.72% | 2.20% | 2030-09-02 | 3.19 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5035516Royalty Pharma plc 1.2% 02-SEP-2025 | 1.30% | 0 | 99.62% | 1.20% | 2025-09-02 | 38 K USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |